Efficacy and Safety of Automated Closed-loop Ventilator vs Conventional Open-loop Ventilator in the Emergency Department (AVAC)

November 27, 2023 updated by: Dr. Khadijah Poh Yuen Yoong, University of Malaya

A Randomized, Controlled Trial to Evaluate the Efficacy and Safety of Fully Automated Closed-loop Ventilator Versus Conventional Open-loop Ventilator in Ventilated Patients in the Emergency Department

Patients presenting to the emergency department (ED) may require breathing support with machines depending on the condition. Throughout the breathing support, the settings on the breathing machines will be tailored to the patient's requirements. These settings are manually adjusted by trained physicians. Currently, there are machines which can automatically change the settings based on real-time specific information obtained from the patient. This study aims to compare the use of machines which require manual adjustments (open-loop conventional ventilators) and machines which can automatically change the settings (closed-loop automated ventilators). Patients will be carefully selected to ensure no harm is caused whilst delivering the best care. This study will look into the duration when patients are receiving optimum settings and levels of oxygen and carbon dioxide in the blood. The outcomes of this study would allow us to identify methods to improve patient care.

Study Overview

Detailed Description

Invasive mechanical ventilation is a lifesaving intervention for patients with respiratory failure in the emergency department (ED). Recent technological advancements have introduced closed-loop automated ventilators as a potential alternative to open-loop conventional ventilators. However, the efficacy and safety of closed-loop automated ventilators in the emergency setting remains understudied. This research aims to evaluate the efficacy and safety of closed-loop automated ventilator compared to open-loop conventional ventilator in intubated and ventilated patients in the ED.

A randomized controlled trial will be conducted in an ED of a tertiary university-affiliated hospital. Eligible patients are 18 years or older, decision made by treating physicians to intubate and mechanically ventilate. Some of exclusion criteria are pregnancy, heart failure, metabolic acidosis, circulatory shock, life-threatening asthma and morbid obesity. The primary measure of efficacy is the duration of ventilation within a predefined range of acceptable respiratory parameters between automated and conventional ventilation. Secondary outcome measures are; number of manual adjustments required to attain targeted settings in automated and conventional ventilators, PaO2/FiO2 ratio (PF ratio), arterial blood gas results, vital signs, breath-by-breath analysis, and rate of ventilator dyssynchrony. The ventilator used in the intervention arm is the closed-loop automated ventilator Hamilton C6s INTELLIVENT-ASV (Hamilton Medical AG, Switzerland). Hamilton C1 ASV is chosen as the open-loop conventional comparator as it is similar to Hamilton C6s INTELLIVENT-ASV, without the INTELLIVENT software.

Based on Lellouche et al, the calculated total sample size with a dropout rate of 10% is 132. The data is analysed based on the intention-to-treat (ITT) and per-protocol (PP) principles. The primary endpoint measurements are reported as areas under the curves (AUC) within the predefined range of acceptable respiratory parameters. Between-group differences in continuous variables are analysed using independent t-test or Mann-Whitney U test. Between-group differences in categorical variables are analysed using chi-square test.

Study Type

Interventional

Enrollment (Estimated)

132

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Decision made by treating physicians to intubate and mechanically ventilate

Exclusion Criteria:

  1. Suspected or confirmed pregnancy.
  2. Known right ventricular heart failure upon assessment for recruitment.
  3. Severe metabolic acidosis upon intubation (pH <7.2 or bicarbonate <12 mmol/L)
  4. Circulatory shock requiring noradrenaline more than 0.5 mcg/kg/min upon assessment for recruitment.
  5. Severe or acute life-threatening asthma.
  6. Patients with chest wall deformities that would affect ventilation (e.g. severe kyphoscoliosis, diaphragmatic hernia, flail chest, trauma, pectus excavatum or carinatum, ankylosing spondylitis
  7. Patients with previous lobectomy or pneumonectomy.
  8. Patients with pneumothorax or other condition that requires chest drainage tube.
  9. Patients with body mass index > 40 kg/m2.
  10. Manufacturer's contraindications:

    • Difference in oxygen saturation between pulse oximetry (SpO2) and arterial sample (SaO2) of more than 5% (due to unreliable sensor).
    • Difference in carbon dioxide level between end-tidal sensor (ETCO2) and arterial sample (PaCO2) of more than 5 mm Hg (due to unreliable sensor).
    • Known pneumothorax and bronchopulmonary fistula upon assessment for recruitment.
  11. Participation in another interventional trial.
  12. Do-not-attempt-resuscitation (DNAR) order.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Open-loop ventilator
Prior to the rapid sequence intubation, patients' gender and height are set on the ventilator. The physician in-charge will setup the ventilator based on the lung condition, following the research protocol. Patients will be connected to this ventilator upon securing the airway. Ventilator setting parameters will be manually adjusted by the in-charge physician following local guidelines.
Conventional closed-loop ventilator with manual adjustments by the physician in charge
Experimental: Closed-loop ventilator
Prior to the rapid sequence intubation, patients' gender and height are set on the ventilator. Patients' condition settings are selected depending on the lung condition. The sensors for end-tidal carbon dioxide (EtCO2) and oxygen saturation (SpO2) will be connected. Patients will be connected to this ventilator upon securing the airway. Ventilator setting parameters will be set following the study protocol.
Fully automated closed-loop ventilator using the INTELLIVENT software

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of ventilation within a predefined range of acceptable respiratory parameters
Time Frame: Every 30 seconds for 240 minutes
Duration of ventilation (in minutes) within predefined acceptable tidal volume (TV), plateau pressure, EtCO2 and SpO2
Every 30 seconds for 240 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manual adjustments of ventilator settings
Time Frame: Any time the manual adjustment is performed throughout the 4-hour study period
Frequency of manual adjustments of ventilator settings and the parameters requiring adjustments
Any time the manual adjustment is performed throughout the 4-hour study period
Physiological data - blood pressure
Time Frame: Mean hourly for 4 hours
Patient's blood pressure in mmHg
Mean hourly for 4 hours
Physiological data - respiratory rate
Time Frame: Mean hourly for 4 hours
Patient's respiratory rate in breaths per minute
Mean hourly for 4 hours
Physiological data - heart rate
Time Frame: Mean hourly for 4 hours
Patient's heart rate in beats per minute
Mean hourly for 4 hours
Biochemical data - pH
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Arterial pH levels
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Biochemical data - CO2 and O2
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Arterial partial pressure of carbon dioxide and oxygen in mmHg
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Biochemical data - bicarbonate
Time Frame: Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Arterial bicarbonate levels in mmol/L
Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Patient outcome - mechanical ventilation
Time Frame: Assessed from time of intubation to time of successful extubation or death from any cause, whichever came first, assessed up to 28 days
Duration of mechanical ventilation
Assessed from time of intubation to time of successful extubation or death from any cause, whichever came first, assessed up to 28 days
Patient outcome - LOS ED
Time Frame: Assessed from time of triage to time patient leaves ED or death, whichever comes first, up to 7 days
Length of stay in emergency department
Assessed from time of triage to time patient leaves ED or death, whichever comes first, up to 7 days
Patient outcome - LOS ICU
Time Frame: Assessed from time of admission into the ICU to time of transfer to general ward or death, whichever comes first up to 28 days
Length of intensive care unit stay
Assessed from time of admission into the ICU to time of transfer to general ward or death, whichever comes first up to 28 days
Patient outcome - LOS hospital
Time Frame: Assessed from time of triage in ED to time of discharge or in-hospital death, whichever comes first up to 28 days
Length of hospital stay
Assessed from time of triage in ED to time of discharge or in-hospital death, whichever comes first up to 28 days
Mortality rate
Time Frame: At 14 and 28 days after recruitment
Number and percentage of deaths
At 14 and 28 days after recruitment
Number of patients developing ARDS and pneumothorax
Time Frame: At anytime within the 4-hour intervention or upon discharge or diagnosis of complications
Development of complications (pneumothorax, ARDS) during study and throughout admission
At anytime within the 4-hour intervention or upon discharge or diagnosis of complications
Ventilator data - airway pressures
Time Frame: Every 30 seconds for 240 minutes
Ventilator parameters: mean and peak airway pressures in cmH20
Every 30 seconds for 240 minutes
Ventilator data - FiO2
Time Frame: Every 30 seconds for 240 minutes
Ventilator parameters: fraction of inspired oxygen (FiO2)
Every 30 seconds for 240 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Khadijah Poh, MMed, University of Malaya

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2024

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

November 16, 2023

First Submitted That Met QC Criteria

November 27, 2023

First Posted (Estimated)

December 5, 2023

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023317-12254
  • NMRR ID-23-03290-LRC (Registry Identifier: National Medical Research Register)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data for this study will not be made publicly available. However, summary results and study outcomes will be transparently reported in the form of aggregated data and CSV files. This approach ensures that key findings are accessible while respecting participant confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ARDS

Clinical Trials on Open-loop ventilator

Subscribe